Search

This pilot pre-clinical study demonstrates the applicability of a new type of pneumatic cardiac triggering (PCT) for cardiac imaging. The pilot research compares the novel FPGA-based pad monitoring system for cardiac triggering using ballistocardiography (BCG) with conventional systems based on electrocardiography (ECG) and photoplethysmography (PPG). The implemented system enables cardiac triggering without the need to fix the sensors to the patient's body. This unique approach has the potential to reduce the preparation time for examination and the examination itself and to increase patient's comfort. The pilot pre-clinical study was conducted on 10 subjects at the Siemens Prisma 3T MRI Scanner within the CEITEC Multimodal and Functional Imaging Laboratory - Central European Institute of Technology, Masaryk University, upon the approval of the Ethics Committee. In total, 748 peaks (heart beats) were detected, with 7.347 correctly identified as true positive peaks, 140 incorrectly detected as false positive peaks, and 106 missed peaks (false negative). For all subjects, the total accuracy reached 96.31% and F1 score reached 98.18%. The applicability of the proposed BCG system was also analyzed in terms of objective (BRISQUE, NIQE, PIQE) and subjective evaluation of the images by 10 experts. The study compares images from two basic cardiac sequences - TRUE FISP (Free Induction Decay Steady-State Precession) and PSIR (Phase Sensitive Inversion Recovery) sequences. The BCG system achieves comparable results with the most frequently used and most accurate clinical ECG system used as gold standard. The results prove that the BCG signal captured by our new sensor can be used as a substitute for ECG signal during MRI exam with reliability of 97%.

This first-ever study demonstrates the applicability of a fiber Bragg grating (FBG) system for MR cardiac triggering of cardiovascular magnetic resonance at 3 Tesla. The unique patented system senses body movements caused by cardiac activity using a non-invasive ballistocardiography (BCG) sensor. The pilot research compares a novel FBG-based system with clinically used triggering systems based on electrocardiography (ECG) and pulse oximetry (POX). The pilot pre-clinical study was conducted on 8 subjects at a Siemens Prisma 3T MR Scanner. The study compares images from two basic cardiac sequences, TRUE FISP (Free Induction Decay Steady-State Precession) and PSIR (Phase Sensitive Inversion Recovery), using objective methods and subjective evaluation by clinical experts. The study presents original results that confirm the applicability of optical sensors in the field of cardiac triggering having a number of advantages in comparison to conventional solutions, such as no eddy current interference, ease of placement of the sensor on the patient's body, and senor reusability. The proposed FBG-based system achieves comparable results with the most frequently used and most accurate ECG-based and POX-based clinical systems. In terms of subjective evaluation by experts, the FBG system outperformed the POX-based system used in clinical practice.

This study describes a pilot clinical validation of a new low-cost system for the continuous monitoring of the human body's cardiorespiratory activities within the magnetic resonance examination area. This study primarily focuses on monitoring cardiac activity and the related cardiac triggering. The patented system tested by the authors is based on seismocardiography (SCG). The study was conducted on 18 subjects on a Siemens Prisma 3T MR scanner. Standard anatomical and diffusion sequences were used to test cardiac activity monitoring. A wide range of commonly used diagnostic sequences were used to test imaging of the heart by means of cardiac triggering. System functionality was verified against a commercially available electrocardiography (ECG) system. Monitoring of cardiac activity (detection of the R-R interval in ECG and the AO-AO interval in SCG) was objectively evaluated by determining the overall probability of correct detection (ACC), sensitivity (SE), positive predictive value (PPV), and harmonic mean between SE and PPV, i.e. F1. Imaging quality control using Cardiac Triggering was performed by subjective evaluation of images by the physicians. The study conducted clearly confirmed the functionality of the system in terms of continuous cardiac activity monitoring. In all 18 subjects, a mean PPV > 99 % was achieved; F1 > 99 %; SE > 99 %; ACC > 98 %; 1.96σ

This publication describes an original simple low-cost MR fully-compatible and safe fiber-optic breathing sensor (FOBS), which can be used for respiratory triggering and for monitoring the development of respiratory rate within the MR environment and can, thus, serve as prevention from the hyperventilation syndrome. The sensor is created by encapsulation of the Bragg grating into conventional nasal oxygen cannulas. The sensor is immune to minor patient movements, thus limiting movement artifacts to a minimum. Thanks to this fact it can be used for the retrospective/prospective respiratory gating. The sensor is immune to electromagnetic interference (EMI) and can thus be used in any magnetic field (1.5T, 3T, and 7T). The sensor prototype has been tested in both laboratory and real magnetic resonance (3T) environments relative to conventional pneumatic respiration references (PRR). The data measured were statistically evaluated using the objective Bland-Altman method (BAM) and the functionality of the proposed solution was confirmed. Respiratory Triggering functionality was confirmed by the radiologic doctors on the basis of analyzing images using the most used respiratory triggered T2 TSE 3D sequences and by objective method using the Blind/Referenceless Image Spatial Quality Evaluator (BRISQUE).